{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:35:48Z","timestamp":1782531348387,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012434","name":"Irving A Hansen Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002234","name":"Don Monti Memorial Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150763","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:45:15Z","timestamp":1727484315000},"page":"150763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Famotidine increases cellular phospho-tyrosine levels"],"prefix":"10.1016","volume":"734","author":[{"given":"Imanol","family":"Zubiete-Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150763_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118275","article-title":"Utilizing drug repurposing against COVID-19 \u2013 efficacy, limitations, and challenges","volume":"259","author":"Parvathaneni","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.150763_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jphs.2022.04.007","article-title":"Drug repurposing for the treatment of COVID-19","volume":"149","author":"Kato","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2024.150763_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2024.150763_bib4","author":"Cataldi"},{"key":"10.1016\/j.bbrc.2024.150763_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050051","article-title":"Association of the patterns of use of medications with mortality of COVID-19 infection: a hospital-based observational study","volume":"11","author":"Wallace","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbrc.2024.150763_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2024.150763_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.antiviral.2013.11.004","article-title":"Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors","volume":"101","author":"Kilianski","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2024.150763_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41431-022-01108-8","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: intracellular overdrive for SARS-CoV-2 infection","volume":"30","author":"Jamison","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150763_bib9","doi-asserted-by":"crossref","first-page":"PL365","DOI":"10.1016\/S0024-3205(96)00553-X","article-title":"The effect of histamine type 2 receptor antagonists on human immunodeficiency virus (HIV) replication: identification of a new class of antiviral agents","volume":"59","author":"Bourinbaiar","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.150763_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2020.05.053","article-title":"Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study","volume":"159","author":"Freedberg","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2024.150763_bib11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/gutjnl-2020-321852","article-title":"Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series","volume":"69","author":"Janowitz","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2024.150763_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.633680","article-title":"COVID-19: famotidine, histamine, mast cells, and mechanisms","volume":"12","author":"Malone","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150763_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100925","article-title":"Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection","volume":"297","author":"Mukherjee","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150763_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.150763_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.bbrc.2024.150763_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP \u2013 nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2024.150763_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158199","article-title":"PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils","volume":"7","author":"Song","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2024.150763_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.589505","article-title":"Cathepsin L in COVID-19: from pharmacological evidences to genetics","volume":"10","author":"Gomes","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbrc.2024.150763_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2165\/00003088-199121030-00003","article-title":"Clinical pharmacokinetics of famotidine","volume":"21","author":"Echizen","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2024.150763_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2016.02.047","article-title":"The dark side of cell signaling: positive roles for negative regulators","volume":"164","author":"Lemmon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150763_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cell.2005.05.016","article-title":"Redox redux: revisiting PTPs and the control of cell signaling","volume":"121","author":"Tonks","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150763_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ab.2005.07.026","article-title":"Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates","volume":"345","author":"Meng","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2024.150763_bib23","doi-asserted-by":"crossref","first-page":"eabj3624","DOI":"10.1126\/science.abj3624","article-title":"A prenylated dsRNA sensor protects against severe COVID-19","volume":"374","author":"Wickenhagen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150763_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adg5470","article-title":"Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19","volume":"16","author":"Carrau","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2024.150763_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150763_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/BJ20120541","article-title":"USP18 establishes the transcriptional and anti-proliferative interferon \u03b1\/\u03b2 differential","volume":"446","author":"Francois-Newton","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2024.150763_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/ars.2018.7525","article-title":"Regulation of NADPH oxidases by G protein-coupled receptors","volume":"30","author":"Petry","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.bbrc.2024.150763_bib28","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1089\/ars.2013.5602","article-title":"Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling, antioxid","volume":"20","author":"De Deken","year":"2014","journal-title":"Redox Signal."},{"key":"10.1016\/j.bbrc.2024.150763_bib29","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1089\/ars.2009.2558","article-title":"Mechanisms and function of DUOX in epithelia of the lung","volume":"11","author":"Fischer","year":"2009","journal-title":"Antioxidants Redox Signal."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T19:33:16Z","timestamp":1732649596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24012993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"alternative-id":["S0006291X24012993"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150763","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Famotidine increases cellular phospho-tyrosine levels","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150763"}}